NCM

NEXTBio Capital Management Portfolio holdings

AUM $215M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$215M
AUM Growth
+$44.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
24
New
Increased
Reduced
Closed

Top Buys

1
+$8.53M
2
+$5.69M
3
+$2.66M
4
ZBIO
Zenas BioPharma
ZBIO
+$2.35M
5
TERN
Terns Pharmaceuticals
TERN
+$2.19M

Top Sells

1
+$1.53M
2
+$1.05M
3
+$1,000K
4
XENE icon
Xenon Pharmaceuticals
XENE
+$22.1K
5
PCVX icon
Vaxcyte
PCVX
+$14.2K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TERN
1
DELISTED
Terns Pharmaceuticals
TERN
$31.9M 14.8%
604,534
+53,344
PTGX icon
2
Protagonist Therapeutics
PTGX
$6.4B
$24.2M 11.24%
229,619
STTK icon
3
Shattuck Labs
STTK
$456M
$20.3M 9.4%
3,149,907
VOR icon
4
Vor Biopharma
VOR
$811M
$17.8M 8.28%
999,967
CMPS
5
Compass Pathways
CMPS
$1.76B
$11.2M 5.19%
2,021,407
+1,268,776
RYTM icon
6
Rhythm Pharmaceuticals
RYTM
$6.05B
$11M 5.09%
126,078
+58,492
XENE icon
7
Xenon Pharmaceuticals
XENE
$5.29B
$10.7M 4.95%
183,225
-479
PVLA
8
Palvella Therapeutics
PVLA
$1.7B
$10.3M 4.79%
82,686
ZBIO
9
Zenas BioPharma
ZBIO
$1.16B
$8.34M 3.87%
426,736
+104,753
IVA
10
Inventiva
IVA
$1.03B
$7.4M 3.44%
1,333,484
+34,783
VSTM icon
11
Verastem
VSTM
$380M
$6.93M 3.22%
1,306,800
-530
CBIO
12
Crescent Biopharma
CBIO
$569M
$6.85M 3.18%
372,856
ORIC icon
13
Oric Pharmaceuticals
ORIC
$875M
$6.63M 3.08%
523,619
-92,101
GPCR icon
14
Structure Therapeutics
GPCR
$2.8B
$6.42M 2.98%
133,239
+38,796
PCVX icon
15
Vaxcyte
PCVX
$7.42B
$5.53M 2.57%
95,223
-262
COGT icon
16
Cogent Biosciences
COGT
$5.97B
$5.05M 2.34%
131,188
+35,369
CMPX icon
17
Compass Therapeutics
CMPX
$429M
$4.49M 2.08%
848,204
-265,801
EVMN
18
Evommune Inc
EVMN
$837M
$4.23M 1.96%
184,063
-44,223
OCS icon
19
Oculis Holding
OCS
$1.37B
$3.98M 1.85%
149,592
-158
ZLAB icon
20
Zai Lab
ZLAB
$1.99B
$3.45M 1.6%
183,362
+20,000
IRON icon
21
Disc Medicine
IRON
$2.66B
$3.37M 1.56%
52,655
+9,877
KALV icon
22
KalVista Pharmaceuticals
KALV
$1.43B
$2.65M 1.23%
131,796
SMMT icon
23
Summit Therapeutics
SMMT
$13.6B
$1.7M 0.79%
+89,717
ACET icon
24
Adicet Bio
ACET
$87M
$1.07M 0.5%
157,827